Emergent BioSolutions (EBS) EBIT Margin (2011 - 2026)
Emergent BioSolutions (EBS) reported EBIT Margin of -33.91% for Q3 2026, down 67.01 percentage points from 33.10% a year earlier but up 19.48 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBIT Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Emergent BioSolutions' EBIT Margin came in at -27.70%, down 42.72 percentage points year-over-year; for FY2025, it came in at 13.47%, up 23.89 percentage points from FY2024.
- EBIT Margin has a five-year change of -14.33 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -10.42% in FY2024 (+58.81 pp), -69.23% in FY2023 (-54.01 pp), -15.21% in FY2022 (-34.46 pp) and 19.25% in FY2021 (-8.55 pp).
- Five-year quarterly EBIT Margin spans a low of -89.84% in Q1 2023 and a high of 39.13% in Q4 2021.
- Year over year, EBIT Margin has now declined in each of the last four quarters, with an average year-over-year change of -4.85 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q3 2024 (a gain of 111.45 percentage points); the low point was Q1 2023 (a drop of 92.10 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at -53.39% (Q2 2026), 6.73% (Q1 2026) and -18.76% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | -33.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -33.91% |
| Jun 30, 2026 | -53.39% |
| Mar 31, 2026 | 6.73% |
| Dec 31, 2025 | -18.76% |
| Sep 30, 2025 | 33.10% |
| Jun 30, 2025 | 1.14% |
| Mar 31, 2025 | 22.46% |
| Dec 31, 2024 | -4.88% |
| Sep 30, 2024 | 21.95% |
| Jun 30, 2024 | -79.90% |
| Mar 31, 2024 | 13.25% |
| Dec 31, 2023 | -15.84% |
| Sep 30, 2023 | -89.50% |
| Jun 30, 2023 | -86.68% |
| Mar 31, 2023 | -89.84% |
| Dec 31, 2022 | -16.75% |
| Sep 30, 2022 | -18.88% |
| Jun 30, 2022 | -31.45% |
| Mar 31, 2022 | 2.26% |
| Dec 31, 2021 | 39.13% |
API Access
Emergent BioSolutions EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();